Datasheet | March 22, 2011

Biological Sample Repatriation For Clinical Trials

Source: Marken

Once the clinical trial medication and supplies are on site in the different countries involved in the clinical trial the drugs are administered to patients by the investigators. The next stage of the clinical trial involves taking samples from the patients that are then sent back to central laboratories to be tested. The ability to repatriate these samples to destination efficiently and on time is essential to the smooth running of the clinical study. Marken ensures that the time-sensitive and temperature-sensitive products arrive at destination on time every time domestically or internationally.

With our knowledge and expertise we recognise the time, speed and temperature requirements unique to clinical trials. With the ever-increasing global nature of clinical trials the ability to offer global solutions is critical to the success of the project. The ability to provide the services necessary to deliver the biological samples globally on time is vital to ensuring the duration from discovery to development of new drugs is reduced.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online